Neurology Drug Study Does Little for Sage Therapeutics, or Its Partner Biogen

Neurology Drug Study Does Little for Sage Therapeutics, or Its Partner Biogen
Bill Alpert
·3 min read

A drug under development by Sage and Biogen to treat the shaking disorder called essential tremor delivered mixed results in a Phase 2 study.